Established in 1985 as a wholly Zimbabwean, privately-owned company, Varichem Pharmaceuticals manufactures and markets a wide range of quality general pharma and pharma-related products sold both locally and to Zimbabwe’s neighbouring countries. Becoming the first indigenous African company to attain a World Health Organisation (WHO) prequalification in 2010, Varichem aim to address the underwhelming awareness

VARICHEM, one of Zimbabwe’s enduring pharmaceutical firms, is charting its course through Zimbabwe’s turbulent economic environment. The Financial Gazette’s Deputy Editor-in-Chief, Dumisani Ndlela (DN), spoke to the company’s marketing executive, Denis Choguya (DC), to understand how Varichem has navigated the terrain for the past 30 years. DN: I think I have to start by asking

Varichem Pharmaceuticals in Harare has become the third company in sub-Saharan Africa to achieve World Health Organisation (WHO) prequalification for a medicines product. Additional products submitted by companies in Kenya and Tanzania, and Varichem in Zimbabwe, are currently being evaluated by PQP. WHO said this was a first for Zimbabwe. PQP regularly organises training and